Emily Rollins - Jan 30, 2025 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Emily Rollins
Stock symbol
DLB
Transactions as of
Jan 30, 2025
Transactions value $
-$84,900
Form type
4
Date filed
2/3/2025, 08:27 PM
Previous filing
Nov 12, 2024
Next filing
Feb 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$84.9K -1K -13.35% $84.90 6.49K Jan 30, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares held following the reported transaction included 2,952 shares of Class A common stock underlying restricted stock units, which vest on the date of this Form 4.